Neutralization of (NK-cell-derived) B-Cell Activating Factor by Belimumab Restores Sensitivity of Chronic Lymphoid Leukemia Cells to Direct and Rituximab-Induced NK Lysis
Leukemia - United Kingdom
doi 10.1038/leu.2015.50
Full Text
Open PDFAbstract
Available in full text
Date
February 24, 2015
Authors
Publisher
Springer Science and Business Media LLC